GlobalData’s clinical trial report, “Tetralogy Of Fallot Global Clinical Trials Review, H2, 2013” provides data on the Tetralogy Of Fallot clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tetralogy Of Fallot. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tetralogy Of Fallot. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Tetralogy Of Fallot 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by BRIC Nations 12

Clinical Trials by G7 Nations 13

Clinical Trials in G7 Nations by Trial Status 14

Clinical Trials by E7 Nations 15

Clinical Trials in E7 Nations by Trial Status 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Unaccomplished Trials of Tetralogy Of Fallot 20

Subjects Recruited Over a Period of Time 21

Prominent Drug Comparison 22

Clinical Trial Profiles 23

Clinical Trial Overview of Top Institutes / Government 23

Competence Network for Congenital Heart Defects 23

Clinical Trial Overview of Competence Network for Congenital Heart Defects 23

Emory University 24

Clinical Trial Overview of Emory University 24

The Children's Hospital of Philadelphia 25

Clinical Trial Overview of The Children's Hospital of Philadelphia 25

Leiden University Medical Center 26

Clinical Trial Overview of Leiden University Medical Center 26

University Hospital Inselspital, Berne 27

Clinical Trial Overview of University Hospital Inselspital, Berne 27

Boston Children's Hospital 28

Clinical Trial Overview of Boston Children's Hospital 28

Nationwide Children's Hospital 29

Clinical Trial Overview of Nationwide Children's Hospital 29

British Heart Foundation 30

Clinical Trial Overview of British Heart Foundation 30

National Center for Research Resources 31

Clinical Trial Overview of National Center for Research Resources 31

University of California, San Francisco 32

Clinical Trial Overview of University of California, San Francisco 32

Five Key Clinical Profiles 33

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 62

List of Tables

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8

Tetralogy Of Fallot Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9

Tetralogy Of Fallot Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10

Tetralogy Of Fallot Therapeutics Clinical Trials, North America, Top Countries, 2013* 11

Tetralogy Of Fallot Therapeutics Clinical Trials, BRIC Countries, 2013* 12

Tetralogy Of Fallot Therapeutics Clinical Trials, G7 Countries, 2013* 13

Tetralogy Of Fallot Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14

Tetralogy Of Fallot Therapeutics Clinical Trials, E7 Countries, 2013* 15

Tetralogy Of Fallot Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 16

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Phase, 2013* 17

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 18

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 19

Tetralogy Of Fallot Therapeutics Market, Global, Terminated Clinical Trials, 2013* 20

Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 21

Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 22

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by Competence Network for Congenital Heart Defects, 2013* 23

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 24

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2013* 25

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 26

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2013* 27

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2013* 28

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2013* 29

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by British Heart Foundation, 2013* 30

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 31

Tetralogy Of Fallot Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 32

List of Figures

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8

Tetralogy Of Fallot Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10

Tetralogy Of Fallot Therapeutics Clinical Trials, G7 Countries (%), 2013* 13

Tetralogy Of Fallot Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 17

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 18

Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 19

Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 21

Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 22

GlobalData Methodology 60